Search results
RSV shot shows 90% effectiveness in preventing hospitalization among infants, CDC report says
Journal-News, Hamilton, Ohio via Yahoo News· 2 months agoMar. 12—Nirsevimab, a long-acting monoclonal antibody product, was 90% effective in preventing infants from being hospitalized due to respiratory syncytial virus (RSV) between October 2023 and ...